Claude Science and the Vertical-Integration Trap Is Anthropic becoming pharma’s infrastructure provider—or its future competitor?
Agentic Drug Discovery in 2026: From Tool-Orchestrating Copilots to Lab-in-the-Loop Therapeutic Discovery Building a Drug-Discovery Agent—What Actually Chains, and Where the Wall Is
RNA Therapeutics: The Molecular Language Medicine Is Finally Learning to Speak From silencing genes to rewriting disease biology, RNA medicines are entering their second golden age — and AI may be the accelerator that…
Beyond Minoxidil: The Next Wave of Hair-Loss Therapeutics The emerging therapeutic landscape for androgenetic alopecia. The male pattern baldness pipeline is hot right now. After decades of being…
The Real Cost of AI Coding: Usage Limits, Token Tax, and the Future of Software Development Why Cursor, Copilot, Codex, Claude, Gemini, and Grok are forcing developers to move beyond prompt engineering into context engineering.
The Gut Microbiome Illusion: How India’s Wellness Industry Turned Complex Metagenomics Into… Direct-to-Consumer stool testing kits promise hyper-personalized diets and medical clarity. Recent global consensus and bench validation…
Understanding Cross-Site Scripting (XSS): The Silent Killer of Web Security in 2026 Why this decades-old vulnerability still tops vulnerability lists — and exactly how to defend against it
Reinforcement Learning from Human Feedback (RLHF) The Definitive Guide for Developers and Entrepreneurs in 2026
AlphaEvolve: The AI That Rewrites Its Own Algorithms — And May Reshape Science Forever Google DeepMind’s evolutionary coding agent just repaired DNA sequencing, redesigned quantum circuits, and cracked a 56-year-old…
Harness Engineering: The New Frontier Beyond Prompt Engineering Why 2026’s smartest AI teams aren’t fighting for better models — they’re obsessing over the systems they build around them.
Mastering Amazon Kindle Rankings in 2026 The Complete Playbook for Turning Your Book into a Discoverable Bestseller
In Vivo CAR T Cells: The Drug That Builds Itself Inside You Eight clinical programs, two landmark human datasets, $6B in M&A, and one cautionary tale — a complete field intelligence brief on the most…
Obesity Treatment is a Systems Failure: Why GLP-1 Drugs Will Plateau Without Personalization… This essay has been submitted to Astera. If you are stuck behind a paywall then please click this friend link to read the article.